Page last updated: 2024-09-05

lapatinib and raloxifene

lapatinib has been researched along with raloxifene in 3 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(raloxifene)
Trials
(raloxifene)
Recent Studies (post-2010) (raloxifene)
1,9193051,442128061

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)raloxifene (IC50)
Phospholipase D2Homo sapiens (human)6.1333
Aldehyde oxidase 1Mus musculus (house mouse)0.5
Lysine-specific histone demethylase 1AHomo sapiens (human)2.08
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)1.178
Estrogen receptorHomo sapiens (human)0.0416
Estrogen receptorRattus norvegicus (Norway rat)0.0032
Tyrosine-protein kinase FynHomo sapiens (human)3.666
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)0.282
Alpha-2A adrenergic receptorHomo sapiens (human)1.664
Cytochrome P450 2C9 Homo sapiens (human)2
D(2) dopamine receptorHomo sapiens (human)1.174
Alpha-2B adrenergic receptorHomo sapiens (human)3.698
Alpha-2C adrenergic receptorHomo sapiens (human)0.738
Substance-K receptorHomo sapiens (human)3.989
D(1A) dopamine receptorHomo sapiens (human)3.864
AcetylcholinesteraseHomo sapiens (human)0.4
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.282
Alpha-1D adrenergic receptorHomo sapiens (human)0.973
5-hydroxytryptamine receptor 2AHomo sapiens (human)1.45
5-hydroxytryptamine receptor 2CHomo sapiens (human)1.178
Adenosine receptor A2aHomo sapiens (human)2.111
Sodium-dependent serotonin transporterHomo sapiens (human)3.576
Mu-type opioid receptorHomo sapiens (human)1.176
D(3) dopamine receptorHomo sapiens (human)1.565
Delta-type opioid receptorHomo sapiens (human)6.644
Kappa-type opioid receptorHomo sapiens (human)1.602
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.355
Aldehyde oxidase 1Oryctolagus cuniculus (rabbit)0.008
Sodium-dependent dopamine transporter Homo sapiens (human)1.869
Aldehyde oxidaseHomo sapiens (human)0.0055
Platelet-activating factor acetylhydrolaseHomo sapiens (human)0.0003
Phospholipase D1Homo sapiens (human)4.9167
Aldehyde oxidase 1Macaca fascicularis (crab-eating macaque)0.5
Estrogen receptor betaRattus norvegicus (Norway rat)0.1584
Estrogen receptor betaHomo sapiens (human)0.3051
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.681
Aldehyde oxidase 1 Rattus norvegicus (Norway rat)1.1

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1
Ballard, TE; Henderson, JL; Kalgutkar, AS; Obach, RS; Orr, ST; Ripp, SL; Scott, DO; Sun, H1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

2 review(s) available for lapatinib and raloxifene

ArticleYear
Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.
    Journal of medicinal chemistry, 2012, Jun-14, Volume: 55, Issue:11

    Topics: Animals; Apoproteins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Drug Interactions; Heme; Humans; Models, Biological; Pharmacokinetics; Structure-Activity Relationship; Time Factors

2012
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for lapatinib and raloxifene

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010